Search

everythinglearnresearchcommunity

for

Search:↓

CARI ONE helps start hair growth and makes hair follicles bigger and more numerous.

Pexidartinib often causes liver issues and fatigue, especially in women.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib works well and is safe for treating alopecia areata.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Baricitinib is effective as a treatment for severe hair loss.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Tofacitinib treatment is used for teenagers with alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.